Log in
E-mail
Password
Show password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

BIOSIG TECHNOLOGIES, INC.

(BSGM)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsOther languagesPress ReleasesOfficial PublicationsSector news

BIOSIG TECHNOLOGIES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (form 8-K)

12/01/2021 | 09:28am EST

Item 7.01 Regulation FD Disclosure.

On December 1, 2021, BioSig Technologies, Inc. (the "Company") issued a press release, attached hereto as Exhibit 99.1, announcing the appointment of Gray Fleming as Chief Commercial Officer. The Company undertakes no obligation to update, supplement or amend the materials attached hereto as Exhibit 99.1.

In accordance with General Instruction B.2 of Form 8-K, the information in this Item 7.01 of this Current Report on Form 8-K, including Exhibit 99.1, shall not be deemed "filed" for the purposes of Section 18 of the Securities Exchange Act of 1934, as amended (the "Exchange Act"), or otherwise subject to the liabilities of that section, nor shall it be deemed incorporated by reference in any filing under the Exchange Act or the Securities Act of 1933, as amended, except as shall be expressly set forth by reference in such a filing. Furthermore, the furnishing of information under Item 7.01 of this Current Report on Form 8-K is not intended to constitute a determination by the Company that the information contained herein, including the exhibits hereto, is material or that the dissemination of such information is required by Regulation FD.



Item 9.01       Financial Statements and Exhibits.



(d) Exhibits



Exhibit
Number    Description
99.1        Press Release, dated December 1,
          2021 (furnished herewith pursuant to
          Item 7.01)
104       Cover Page Interactive Data File
          (formatted as Inline XBRL)




--------------------------------------------------------------------------------

© Edgar Online, source Glimpses

All news about BIOSIG TECHNOLOGIES, INC.
01/07BioSig to Present at the 27th Annual International AF Symposium
AQ
01/06BioSig to Present at the 24th Annual Virtual Needham Growth Conference
AQ
2021BIOSIG TECHNOLOGIES : Leading healthcare management firm to enhance the Company's market a..
PU
2021BIOSIG TECHNOLOGIES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
2021BioSig Technologies, Inc. Selects Access Strategy Partners to Accelerate Commercial Sal..
GL
2021BIOSIG TECHNOLOGIES : The Company's signal processing technology for arrhythmia care is be..
PU
2021BIOSIG TECHNOLOGIES, INC. : Regulation FD Disclosure, Financial Statements and Exhibits (f..
AQ
2021BioSig Expands Its Clinical Footprint In Florida
GL
2021BioSig Expands Its Clinical Footprint In Florida
GL
2021BioSig Technologies, Inc. Expands its Clinical Footprint in Florida
CI
More news